1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors
    Meeting Abstract

    Postel-Vinay, S.; Italiano, A.; Martin Romano, P.; Cassier, P. A.; Siu, L. L.; Lossos, I. S.; Hilton, J. F.; Mckean, M. A.; Strauss, J.; Falchook, G. S.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: An adaptive choice-based conjoint analysis
    Journal Article

    Knoerl, R.; Berry, D.; Meyerhardt, J. A.; Reyes, K.; Salehi, E.; Thornton, K.; Gewandter, J. S.
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms
    Journal Article

    Dermawan, J. K.; Singer, S.; Tap, W. D.; Nacev, B. A.; Chi, P.; Wexler, L. H.; Ortiz, M. V.; Gounder, M.; Antonescu, C. R.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Management of pelvic sarcoma
    Review

    Lee, J. S.; Kelly, C. M.; Bartlett, E. K.
    European Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumor
    Review

    Tap, W. D.; Healey, J. H.
    Tumor Biology (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
    Journal Article

    Schöffski, P.; George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Serrano, C.; Jones, R. L.; Attia, S.; D’Amato, G.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • A phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 (ezabenlimab) and BI 754111 in patients (pts) with advanced solid tumors
    Meeting Abstract

    Yamamoto, N.; Hafez, N.; Tolcher, A. W.; Teufel, M.; Geng, J.; Svensson, L.; Lahmar, M.; Gounder, M. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Navtemadlin (KRT-232) activity after failure of anti-PD-1/L1 therapy in patients (pts) with TP53WT Merkel cell carcinoma (MCC)
    Meeting Abstract

    Wong, M. K. K.; Burgess, M. A.; Chandra, S.; Schadendorf, D.; Silk, A. W.; Olszanski, A. J.; Grob, J. J.; Jang, S.; Grewal, J. S.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor
    Meeting Abstract

    Tap, W. D.; Wagner, A. J.; Sharma, M. G.; Vallee, M.; Michenzie, M. F.; Sherman, M. L.; Ruiz-Soto, R.; Stacchiotti, S.; van de Sande, M. A. J.; Gelderblom, H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save